These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23419165)

  • 1. Challenges in drug target discovery in bipolar disorder.
    Alsaif M; Haenisch F; Guest PC; Rahmoune H; Bahn S
    Expert Opin Ther Targets; 2013 May; 17(5):565-77. PubMed ID: 23419165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel routes to bipolar disorder drug discovery.
    Hoertel N; de Maricourt P; Gorwood P
    Expert Opin Drug Discov; 2013 Aug; 8(8):907-18. PubMed ID: 23706065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic approaches for bipolar disorder drug discovery.
    Peedicayil J
    Expert Opin Drug Discov; 2014 Aug; 9(8):917-30. PubMed ID: 24875048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs under early investigation for the treatment of bipolar disorder.
    Konstantakopoulos G; Dimitrakopoulos S; Michalopoulou PG
    Expert Opin Investig Drugs; 2015 Apr; 24(4):477-90. PubMed ID: 25704484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in bipolar disorder drug design toward the development of novel therapeutic targets: a clinician's perspective.
    Fornaro M; Kardash L; Novello S; Fusco A; Anastasia A; De Berardis D; Perna G; Carta MG
    Expert Opin Drug Discov; 2018 Mar; 13(3):221-228. PubMed ID: 29357703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could the underestimation of bipolarity obstruct the search for novel antidepressant drugs?
    Fornaro M; Aguglia E; Dell'Osso L; Perugi G
    Expert Opin Pharmacother; 2011 Dec; 12(18):2817-31. PubMed ID: 22098226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers.
    Gould TD; Quiroz JA; Singh J; Zarate CA; Manji HK
    Mol Psychiatry; 2004 Aug; 9(8):734-55. PubMed ID: 15136794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder.
    Dodd S; Fernandes BS; Dean OM
    Curr Neuropharmacol; 2015; 13(5):656-62. PubMed ID: 26467413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen synthase kinase-3: a target for novel bipolar disorder treatments.
    Gould TD; Zarate CA; Manji HK
    J Clin Psychiatry; 2004 Jan; 65(1):10-21. PubMed ID: 14744163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic use of omega-3 fatty acids in bipolar disorder.
    Balanzá-Martínez V; Fries GR; Colpo GD; Silveira PP; Portella AK; Tabarés-Seisdedos R; Kapczinski F
    Expert Rev Neurother; 2011 Jul; 11(7):1029-47. PubMed ID: 21721919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurobiology of bipolar disorder.
    Newberg AR; Catapano LA; Zarate CA; Manji HK
    Expert Rev Neurother; 2008 Jan; 8(1):93-110. PubMed ID: 18088203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: novel hypothesis-driven treatments for bipolar depression?
    Soczynska JK; Kennedy SH; Goldstein BI; Lachowski A; Woldeyohannes HO; McIntyre RS
    Neurotoxicology; 2009 Jul; 30(4):497-521. PubMed ID: 19477018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gsk3 Signalling and Redox Status in Bipolar Disorder: Evidence from Lithium Efficacy.
    Luca A; Calandra C; Luca M
    Oxid Med Cell Longev; 2016; 2016():3030547. PubMed ID: 27630757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second messengers and their importance for novel drug treatments of patients with bipolar disorder.
    Sani G; Kotzalidis GD; Fiaschè F; Manfredi G; Ghaemi SN
    Int Rev Psychiatry; 2022; 34(7-8):736-752. PubMed ID: 36786113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The multicellular tumor spheroid model for high-throughput cancer drug discovery.
    LaBarbera DV; Reid BG; Yoo BH
    Expert Opin Drug Discov; 2012 Sep; 7(9):819-30. PubMed ID: 22788761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin dysfunction and allostatic load in bipolar disorder.
    Brietzke E; Kapczinski F; Grassi-Oliveira R; Grande I; Vieta E; McIntyre RS
    Expert Rev Neurother; 2011 Jul; 11(7):1017-28. PubMed ID: 21721918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinases as drug targets in the treatment of bipolar disorder.
    Catapano LA; Manji HK
    Drug Discov Today; 2008 Apr; 13(7-8):295-302. PubMed ID: 18405841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network approaches to drug discovery.
    Chandra N; Padiadpu J
    Expert Opin Drug Discov; 2013 Jan; 8(1):7-20. PubMed ID: 23140510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Models and discovery strategies for new therapies of retinoblastoma.
    Houston SK; Lampidis TJ; Murray TG
    Expert Opin Drug Discov; 2013 Apr; 8(4):383-94. PubMed ID: 23427911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.